The diagnostic yield for FH proband genetic testing is lower in postmenopausal women when fixed LDL-C decision thresholds are used

• A. Luvai,
• R. O'Leary,
• S. Urwin,
• J. Allen,
• D. Reay,
• L. Ingoe,
• A. Potter,
• S. Musson,
• S. Pattman,
• N. Hopper,
• C. McAnulty,
• R.D.G. Neely,
• P.E. Carey

Affiliations

A. Luvai

Corresponding author.; The Lipid Clinic; Northern Lipid Specialists Advisory Group

R. O'Leary

Northern Medical Physics and Clinical Engineering, The Newcastle upon Tyne Hospitals NHS Foundation Trust

S. Urwin

The National Institute for Health Research Newcastle In-Vitro Diagnostics Co-operative, The Newcastle upon Tyne Hospitals NHS Foundation Trust

J. Allen

The National Institute for Health Research Newcastle In-Vitro Diagnostics Co-operative, The Newcastle upon Tyne Hospitals NHS Foundation Trust

D. Reay

Northern Genetics Service

L. Ingoe

Northern Genetics Service

A. Potter

Northern Genetics Service

S. Musson

Northern Genetics Service

S. Pattman

Northern Lipid Specialists Advisory Group

N. Hopper

Great North Children’s Hospital, Newcastle Upon Tyne NHS Foundation Trust; Northern Lipid Specialists Advisory Group

C. McAnulty

Northern Genetics Service

R.D.G. Neely

Northern Lipid Specialists Advisory Group; Academic Health Science Network

P.E. Carey

Northern Lipid Specialists Advisory Group